Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
AUTOR(ES)
Novello, S
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778527Documentos Relacionados
- A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
- Advanced non-small cell lung cancer – treatment with Pembrolizumab
- Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews
- Chemotherapy for advanced non-small cell lung cancer in the elderly population
- Advanced non-small cell lung cancer associated with hemophagocytic syndrome in a cachectic patient